Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment

      Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatment

      Medical Dialogues Bureau12 April 2020 1:54 PM IST
      New York: U.S. drugmaker Pfizer Inc said on Thursday that early data has helped it identify a drug candidate with the potential to help treat patients...
      NPPA fixes prices of 29 formulations under DPCO, check out details

      NPPA fixes prices of 29 formulations under DPCO, check out details

      Medical Dialogues Bureau12 April 2020 1:37 PM IST
      Many of the drugs whose price has been fixed includes popular cardio-diabetes products, paracetemol combinations, and many more
      Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung inflammation after COVID-19 infection

      Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung inflammation after COVID-19 infection

      Medical Dialogues Bureau12 April 2020 1:30 PM IST
      Vazegepant is currently advancing to Phase 3 development for the acute treatment of migraines in adults under the Division of Neurology, having...
      GSK , Vir Biotechnology enter collaboration to find coronavirus solutions

      GSK , Vir Biotechnology enter collaboration to find coronavirus solutions

      Medical Dialogues Bureau12 April 2020 10:45 AM IST
      London, UK and San Francisco, US: GlaxoSmithKline plc and Vir Biotechnology, Inc. have announced that they have signed a binding agreement to enter...
      India should become self-reliant in medical equipment, devices: Kasturirangan

      India should become self-reliant in medical equipment, devices: Kasturirangan

      Medical Dialogues Bureau12 April 2020 9:00 AM IST
      Bengaluru: India needs to come out with a policy to make the country self-reliant in the field of medical equipment and devices drawing lessons from...
      Cancer tech Patent Infringment: Gilead Sciences told to pay 1.2 billion dollars to Bristol-Myers Squibb

      Cancer tech Patent Infringment: Gilead Sciences told to pay 1.2 billion dollars to Bristol-Myers Squibb

      Medical Dialogues Bureau11 April 2020 1:56 PM IST
      USA: A federal judge increased to $1.2 billion the damages that Gilead Sciences Inc must pay to Bristol-Myers Squibb Co in a patent infringement...
      Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

      Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturers

      Medical Dialogues Bureau11 April 2020 1:18 PM IST
      New Delhi: With a recent notification, the Central Government has given powers to the National Pharmaceutical Pricing Authority (NPPA) under the...
      Zydus gets USFDA tentative nod for Empagliflozin Tablets

      Zydus gets USFDA tentative nod for Empagliflozin Tablets

      Medical Dialogues Bureau11 April 2020 12:17 PM IST
      Ahmedabad: Zydus Cadila has received tentative approval from the USFDA to market Empagliflozin Tablets, in the strengths of 10 mg and 25 mg (US RLD:...
      Dr Reddys Labs receives EIR for Nalgonda-based API plant

      Dr Reddy's Labs receives EIR for Nalgonda-based API plant

      Medical Dialogues Bureau11 April 2020 11:03 AM IST
      New Delhi: Dr Reddy's Laboratories has announced that it has received an establishment inspection report (EIR) from the US health regulator for its...
      Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries

      Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries

      Medical Dialogues Bureau11 April 2020 9:30 AM IST
      Paris: French pharma major Sanofi said on Friday it has decided to donate 100 million doses of hydroxychloroquine, the anti-malaria drug which could...
      Centre steps up efforts to ensure availability of medical oxygen

      Centre steps up efforts to ensure availability of medical oxygen

      Medical Dialogues Bureau11 April 2020 9:00 AM IST
      Thiruvananthapuram: After seeing several countries facing problem due to lack of medical oxygen, the Indian government is making all possible efforts...
      Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

      Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

      Medical Dialogues Bureau10 April 2020 1:00 PM IST
      Hyderabad: Aurobindo Pharma Limited has announced that the Company has received the final approval from the US Food & Drug Administration (USFDA)...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok